Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2008-03-24
Summary
Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis.
* Trial with surgical intervention
Conditions
Interventions
- PROCEDURE
-
No intervention
No intervention
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Completion
- 2012-09-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
Study the Impact of Statins in Septic Shock
NCT02681653 ·Status: COMPLETED ·Phase: NA
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Early Identification of Sepsis in Children
NCT03884595 ·Status: UNKNOWN
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Platelet Reactivity in Septic Shock
NCT03716310 ·Status: COMPLETED
-
Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
NCT02294695 ·Status: COMPLETED
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock
NCT02876341 ·Status: COMPLETED
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
Activated Protein C and Corticosteroids for Human Septic Shock
NCT00625209 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Preclinical Detection of Sepsis Early in Hospitalized Patients Following Surgery, Injury or Severe Illness
NCT04189549 ·Status: UNKNOWN
-
Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis
NCT03506152 ·Status: COMPLETED
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)
NCT01139489 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
NCT01486524 ·Status: UNKNOWN
-
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
NCT06143137 ·Status: RECRUITING
-
Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
NCT01411670 ·Status: COMPLETED ·Phase: PHASE2
-
Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis
NCT01362504 ·Status: COMPLETED
-
New Strategy to Predict Early Sepsis
NCT04118179 ·Status: UNKNOWN